Carter Robert Ross insider trades
Carter Robert Ross has filed 12 Form 4s with the SEC that we hold, all for Starling Oncology, Inc. (TOI), as Chief Financial Officer. Across all of them we count 1 purchase worth $9.4K and 1 sale worth $879 reported on Form 4. In the last 12 months: 0 purchases ($0) and 1 sale ($879). The largest single trade was a purchase of 9,056 shares of Starling Oncology, Inc. worth $9.4K, dated 2025-03-26. The first filing on our record is dated 2024-11-21 and the latest 2026-05-22.
Starling Oncology, Inc. (TOI)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2025-03-26 | P, purchase reported on Form 4 | 9,056 | $9.4K | 2025-03-28 |
| 2026-01-02 | S, sale reported on Form 4 | 247 | $879 | 2026-01-05 |
Counted from the Form 4 filings this reporting owner (SEC CIK 2039341) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms